Home » Newsletters » BioWorld Science

BioWorld Science

July 23, 2014

View Archived Issues

Development of a live-attenuated HIV-1 virus incapable of reactivation

Passive immunization against N-terminally truncated beta-amyloid species with NT4X-167 tested

Enrollment open in phase I study of SM-04755 in colorectal, gastric, hepatic or pancreatic cancer

Celladon in-licenses gene therapy application rights for mSCF for cardiac ischemia treatment

MetaMax initiates phase I/IIa study of MM-D37K

Shire recaps progress of second quarter 2014

Cerecor raises funds to support development of pipeline

Sorrento Therapeutics receives NCI grant for Myc inhibitor

NIBIB award supports Celsion's development of ThermoDox for brain tumors

Implantation of cells secreting NGF proves safe in Alzheimer's disease study

Cadila Healthcare discloses new PARP-1 inhibitors

Celon Pharma describes novel PDE9A inhibitors with procognitive potential

Shionogi patents novel cephems

Researchers present phase II data for ELND-005

Roche synthesizes novel COMT inhibitors

Scientists at OriBase Pharma divulge novel protein kinase inhibitors

FDA grants orphan drug status to palovarotene for FOP

European group designs new agents for viral infections

Ganetespib advances into phase III extension of AML LI-1 study

Pierre Fabre presents novel agents for schizophrenia and other disorders

Anavex Life Sciences secures cGMP manufacturing for ANAVEX 2-73

Sage Therapeutics receives fast track designation for SAGE-547

Kyorin signs license agreement with Merck & Co. for vibegron

First phase I trial of JZP-386 begins

Teva acquires Labrys and enhances migraine portfolio

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....